Polyester dendritic systems for drug delivery applications: Design, synthesis, and characterization

Bioconjugate Chemistry

Volumn 13, Issue 3, 2002, Pages 443-452

  Ihre, Henrik R ^a   Padilla de Jesús, Omayra L ^a   Szoka Jr , Francis C ^b   Fréchet, Jean M J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; DRUG DELIVERY; FUNCTIONAL POLYMERS; PROPIONIC ACID; TUMORS;

APPLICATION DESIGN; APPLICATION SYNTHESIS; APPLICATIONS CHARACTERIZATIONS; DENDRITIC SYSTEMS; DESIGN SYNTHESIS; DRUG DELIVERY APPLICATIONS; HIGH-MOLECULAR WEIGHT POLYMERS; SYNTHESIS AND CHARACTERIZATIONS; TARGETING EFFICACIES; TUMOR-TARGETING;

DENDRIMERS;

2,2 BIS(HYDROXYMETHYL) PROPIONIC ACID; 2,2-BIS(HYDROXYMETHYL)-PROPIONIC ACID; ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; DRUG CARRIER; POLYESTER; PROPIONIC ACID DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DESIGN; PH; SYNTHESIS;

ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HYDROGEN-ION CONCENTRATION; POLYESTERS; PROPIONIC ACIDS;

EID: 0036000121     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc010102u     Document Type: Article

References (46)

1. Structure and properties of pharmacologically active polymers
2. Water-soluble polymers in medicine
3. Soluble biomedical polymers
4. Soluble polymers in mediciney
5. HPMA copolymer-anticancer drug conjugates: Design, Activity and mechanism of action
6. Drug-polymer conjugates: Potential for improved chemotherapy
7. Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo
8. Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier
9. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS
10. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review
11. Passive tumor targeting of soluble macromolecules and drug conjugates
12. Doxorubicin-loaded nanospheres bypass tumour cell multidrug resistance
13. Targetable HPMA copolymer-adriamycin conjugates: Recognition, internalization, and subcellular fate
14. Phase I clinical and pharmacokinetic study of PK1 [N-(2-Hydroxypropyl)methacrylamide Copolymer Doxorubicin]: First member of a new class of chemotherapeutic agents-drug-polymer conjugates
15. Polymeric drugs based on conjugates of synthetic and natural macromolecules: I. Synthesis and physicochemical characterization
16. Narrow molecular weight distribution precursors for polymer-drug conjugates
17. Genealogically directed synthesis - Starburst cascade dendrimers and hyperbranched structures
18. Functional polymers and dendrimers - Reactivity, molecular architecture, and interfacial energy
19. Methoxy poly(ethylene glycol) and e-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviors
20. Sterically stabilized vesicles
21. Interactions between polymer-grafted membranes in concentrated solutions of free polymer
22. Designing dendrimers for drug delivery
23. Water-soluble dendrimer-poly(ethylene glycol) starlike conjugates as potential drug carriers
24. Design of dendritic macromolecules containing folate or methotrexate residues
25. Convergent synthesis and 'surface' functionalization of a dendritic analogue of poly(ethylene glycol)
26. Water-soluble dendritic unimolecular micelles: Their potential as drug delivery agents
27. Poly(Amidoamine) (PAMAM) dendrimers: From biomimicry to drug delivery and biomedical applications
28. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture
29. Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125i-labeled polyamidoamine dendrimers in vivo
30. Branched polyamines cure prion-infected neuroblastoma cells
31. Dendrimers: Biocompatibility and potential for delivery of anticancer agents
32. Polyester dendritic systems for drug delivery applications: In vitro and in vivo evaluation
33. Targeting of drugs to the liver
34. Hydrolytic kinetics of biodegradable polyester monolayers
35. Branched biodegradable polyesters for parenteral drug delivery systems
36. Double-stage convergent approach for the synthesis of functionalized dendritic aliphatic polyesters based on 2,2-bis(Hydroxymethyl)propanoic acid
37. Poly(Ethylene Glycol) conjugated drugs and prodrugs: A comprehensive review
38. New hydrazone derivatives of adriamycin and their immunoconjugates- a correlation between acid stability and cytotoxicity
39. Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG-diortho ester-lipid conjugate
40. pH sensitive membrane disruptive pegylated polycations
41. Degradation of side-chains of N-2-(Hydroxypropyl)methacrylamide copolymers by lysosomal thiol proteinases
42. Poly(Ethylene Glycol)-doxorubicin conjugates containing B-lactamase-sensitive linkers
43. Chemoselective ligation reactions with proteins, oligosaccharides and cells
44. Preparation of protein conjugates via intermolecular hydrazone linkage